Dyslipidemia and Type 2 diabetes in children below 18 years of age: an approaching avalanche

Bibliography

• American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care 23(3), 381–389 (2000)
   Google Scholar
• Diabetes Education Resource for Children and Adolescents: DER-CA Annual Report. Winnipeg, Canada (2007)
   Google Scholar
• Canadian Diabetes Association Clinical Practice Guideline Expert Committee: Type 2 Diabetes in Children. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can. J. Diabetes 27, S91–S93 (2003)
   Google Scholar
• Taha D: Hyperlipidemia in children with Type 2 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 15(Suppl. 1), 505–507 (2002)
   Google Scholar
• Eppens MC, Craig ME, Cusumano J et al.: Prevalence of diabetes complications in adolescents with Type 2 compared with Type 1 diabetes. Diabetes Care 29(6), 1300–1306 (2006)
   Google Scholar
• Sellers EAC, Yung G, Dean HJ: Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with Type 2 diabetes mellitus. Pediatric Diabetes 8, 384–390 (2007)
   Google Scholar
• Kershnar AK, Daniels SR, Imperatore G et al.: Lipid abnormalities are prevalent in youth with Type 1 and Type 2 diabetes: the SEARCH for Diabetes in Youth Study. J. Pediatr. 149(3), 314–319 (2006)
   Google Scholar
• Dean H, Flett B: Natural history of Type 2 diabetes diagnosed in childhood: long term follow-up in young adult years. Diabetes 51, A24 (2002)
   Google Scholar
• Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG: Effect of youth-onset Type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 296(4), 421–426 (2006)
   Google Scholar
• Napoli C, Glass CK, Witztum JL, Deutsch R, D’Armiento FP, Palinski W: Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 354(9186), 1234–1241 (1999)
   Google Scholar
• Strong JP, Malcom GT, McMahan CA et al.: Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281(8), 727–735 (1999)
   Google Scholar
• Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD: The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin. Chem. Lab. Med. 42(12), 1355–1363 (2004)
   Google Scholar
• Yusuf S, Hawken S, Ounpuu S et al.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364(9438), 937–952 (2004)
   Google Scholar
• Albers JJ, Marcovina S, Imperatore G et al.: Prevalence and determinants of elevated apolipoprotein B and dense LDL in youths with Type 1 and Type 2 diabetes. J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2007-2176 (2007) (Epub ahead of print)
   Google Scholar
• Sniderman AD, Blank D, Zakarian R, Bergeron J, Frohlich J: Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula. Clin. Biochem. 36(7), 499–504 (2003)
   Google Scholar
• Retnakaran R, Zinman B, Connelly PW, Harris SB, Hanley AJ: Nontraditional cardiovascular risk factors in pediatric metabolic syndrome. J. Pediatr. 148(2), 176–182 (2006)
   Google Scholar
• Belay BB, Belamaric PF, Tom-Revzon C: The use of statins in pediatrics: knowledge base, limitations, and future directions. Pediatrics 119(2), 370–380 (2007)
   Google Scholar
• Nadeau KJ, Klingensmith G, Zeitler P: Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J. Pediatr. Gastroenterol. Nutr. 41(1), 94–98 (2005).
   Google Scholar